Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia

European Respiratory Journal

Volumn 20, Issue 5, 2002, Pages 1213-1219

  Watanabe, K ^a   Higuchi, K ^a   Ninomiya, K ^a   Ohshima, T ^a   Aritomi, T ^a   Kawabata, Y ^a   Yoshida, M ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Idiopathic intestitial pneumonia; Nonspecific interstitial pneumonia; Steroid; Transbronchial lung biopsy; Vital capacity

Indexed keywords

HYDROCORTISONE; METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

ADULT; AGED; ARTICLE; CELL INFILTRATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERSTITIAL PNEUMONIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MONONUCLEAR CELL; PATIENT SELECTION; PLOTS AND CURVES; PRIORITY JOURNAL; SPIROMETRY; STEROID THERAPY; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; VITAL CAPACITY;

AGED; BIOPSY, NEEDLE; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; RADIOGRAPHY, THORACIC; TOMOGRAPHY, X-RAY COMPUTED; TOTAL LUNG CAPACITY; VITAL CAPACITY;

EID: 0036849424     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.02.00269302     Document Type: Article

References (24)

1. American Thoracic Society/European Respiratory Society. International multidisciplinary consensus classification of idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
2. Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, Reynolds HY. NIH conference. Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Int Med 1976; 85: 769-788.
3. King TE, Costabel U, Cordier JF, et al. Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000; 161: 646-664.
4. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: Clinical features and their influence on survival. Thorax 1980; 35: 171-180.
5. Erbes R, Schaberg T, Loddenkemper R. Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome? Chest 1997; 111: 51-57.
6. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax 1980; 35: 591-599.
7. Schwartz DA, Helmers A, Galvin JR, et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149: 450-454.
8. Rudd RM, Haslam PL, Turner-Warwick. Cryptogenic fibrosing alveolitis. Relationship of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis 1981; 124: 1-8.
9. Travis WD, Matsui K, Moss J, Ferrans VJ. Idiopathic nonspecific interstitial pneumonia: Prognostic significance of cellular and fibrosing patterns. Survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000; 24: 19-33.
10. Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994; 18: 136-147.
11. Comroe JH, Foster RE, Dubois AB, Briscoe WA, Carlsen E, The lung volumes. In: The Lung. Clinical Physiology and Pulmonary Function Tests. 2nd edn. Chicago, Year Book Medical Publisher, 1973; pp. 7-26.
12. Foster RE, Fowler WS, Bates DV, Lingen BV. The absorption of carbon monoxide by the lungs during breath holding. J Clin Invest 1954; 33: 1135-1145.
13. Burrows B, Kasik JE, Niden AH, Barclay WR. Clinical usefulness of the single-breath pulmonary diffusing capacity test. Am Rev Respir Dis 1961; 84: 789-806.
14. Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985; 312: 152-158.
15. Watanabe K, Senju S, Wen FQ, Shirakusa T, Maeda F, Yoshida M. Factors related to the relapse of bronchiolitis obliterans organizing pneumonia. Chest 1998; 114: 1599-1606.
16. Kirtland SH, Winterbauer RH. Pulmonary function tests and idiopathic pulmonary fibrosis. Simple may be better. Chest 1997; 111: 7-8.
17. Keogh BA, Crystal RG. Clinical significance of pulmonary function tests. Pulmonary function testing in interstitial pulmonary disease. What does it tell us? Chest 1980; 78: 856-865.
18. van Oortegem K, Wallaert B, Marquette C, et al. Determinants of response to immunosuppressive therapy in idiopathic pulmonary fibrosis. Eur Respir J 1994; 7: 1950-1957.
19. Hanson D, Winterbauer RH, Kirtland SH, Wu R. Changes in pulmonary function test results after 1 year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis. Chest 1995; 108: 305-310.
20. Kim TS, Lee KS, Chung MP, et al. Nonspecific interstitial pneumonia with fibrosis: High-resolution CT and pathologic findings. Am J Roentgenol 1998; 171: 1645-1650.
21. Akira M, Inoue G, Yamamoto S, Sakatani M. Non-specific interstitial pneumonia: findings on sequential CT scans of nine patients. Thorax 2000; 55: 854-859.
22. Katzenstein AA. Acute injury patterns: Diffuse alveolar damage and bronchiolitis obliterans- organizing pneumonia. In: Katzenstein and Askin's Surgical Pathology of Non-neoplastic Lung Diseases. 3rd edn. Philadelphia, W.B. Saunders, 1997; pp. 14-47
23. Preeidler KW, Szolar DM, Moelleken S, Tripp B, Schreyer H. Distribution pattern of computed tomography findings in patients with bronchiolitis obliterans organizing pneumonia. Invest Radiol 1996; 31: 251-255.
24. Costabel U, King TE. International consensus statement on idiopathic pulmonary fibrosis. Eur Respir J 2001; 17: 163-167.